Cited by 12Medicinal Plants and NeuroprotectionAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Isolation and neuronal apoptosis inhibitory property of bacoside-A3 via downregulation of β-amyloid induced inflammatory response

Bai, Qing‐ke, Zhao, Zhen‐guo·2022·Biotechnology and Applied Biochemistry

Abstract

Alzheimer's disease is one of the neurodegenerative disorders caused by neuronal degeneration and apoptosis in brain. Bacoside A and B isolated from the Bacopa monniera plant are responsible for cognitive effects. These compounds repair damaged neurons by promoting activity of kinases, synaptic activity restoration, and improvement of nerve transmission. The present study explored the effect of bacoside-A3 on β-amyloid-induced reduction of U87MG cell viability, generation of oxidative radicals, and activation of nuclear factor-κB. The U87MG cells were stimulated with β-amyloid (10 μM) after 24 h of bacoside-A3 pretreatment or without pretreatment to induce characteristics of Alzheimer disease in vitro. Sulforhodamine B (SRB) assay was used to count viable cells and ELISA kit for analysis of PGE2 secretion. The pretreatment with bacoside-A3 prevented β-amyloid-mediated suppression of U87MG cell proliferation. Pretreatment of U87MG cells with bacoside-A3 prior to β-amyloid stimulation suppressed generation of ROS in a concentration-based manner. The β-amyloid-mediated formation of iNOS in U87MG cells was suppressed by bacoside-A3 in a dose-based manner. The β-amyloid-mediated PGE2 secretion was suppressed by bacoside-A3 pretreatment in U87MG cells in the dose-based manner. The overexpression of COX-2 by β-amyloid stimulation was suppressed in bacoside-A pretreated cells in the dose-based manner. The bacoside-A3 pretreatment prevented nuclear translocation of NF-κB in U87MG cells in the dose-based manner. In summary, bacoside-A3 prevented β-amyloid-mediated suppression of U87MG cell viability, inhibited generation of oxidative radicals, PGE2, and synthesis of iNOS. Therefore, bacoside-A3 has therapeutic potential for Alzheimer disease and further in vivo studies need to be performed.

Integrity signals

Registry

Crossref · 10.1002/bab.2147

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bai, Q., & Zhao, Z.
Affiliations
  • Department of Neurology Pudong People's Hospital Shanghai China
  • Department of Radiology Pudong People's Hospital Shanghai China
Venue
Biotechnology and Applied Biochemistry
Publisher
Wiley
Published
2021-04
Volume
69
Issue
2
Pages
726-734
ISSN
  • 0885-4513 (ISSN-L)
  • 1470-8744
OpenAlex
W3134474724
Cited by
12
References
38
Citations by year
2026: 3 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 1
FWCI
1.97
Type
journal article
Language
en
Open access
closed
Locations
  • Biotechnology and Applied Biochemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Bacopa monnieri, Alzheimer's disease, amyloid-beta, neuronal apoptosis, neuroinflammation, oxidative stress, NF-κB, inducible nitric oxide synthase, cyclooxygenase-2, prostaglandin E2, U87 cells, neuroprotection
MeSH terms
Alzheimer Disease, Humans, Neurons, Saponins, Triterpenes, Dinoprostone, Down-Regulation, Amyloid beta-Peptides, NF-kappa B, Apoptosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review